Page 30 - Crispr News Today

In the overflowing file cabinet labeled “What could possibly go wrong?”, human genetic modification and gene editing surely deserve a drawer all their own. One bulging folder would be labeled “Dr. He Jiankui” for the man who edited three human embryos, resulting in the birth of female twins in 2018 and a third female baby

Well-known truth-teller Dr. David Martin told "Thrive Time Show" host Clay Clark that the mRNA Wuhan coronavirus (COVID-19) vaccines are gene therapy designed to harm people. "We [...]

In a new study, scientists have utilised AI to create a protein, and then employ CRISPR technology to it in order to inhibit a protein complex called Polycomb Repressive Complex 2 (PRC2) to awaken and upregulate several genes.

A biophysicist in China was sentenced to three years in 2019 for using the CRISPR gene-editing system to alter the DNA of human embryos.

Ticks have evaded gene editing attempts for years, but scientists have finally figured out how to effectively modify their genome as they work to reduce disease transmission.

It's the second big success story this month in regard to a potentially huge shift in the field of organ transplants. Doctors in Alabama transplanted the kidneys of a genetically...

A genetically modified (GMO) CRISPR tomato manufactured by Sanatech to contain unnaturally high levels of the sedative substance GABA (gamma-aminobutyric acid) has been found to provide no health [...]

This product brochure describes the applications and advantages of Merck’s PURedit™ CRISPR reagents

A team from Salk Institute for Biological Studies in La Jolla, California recently reported details about how plants respond to hormones called jasmonic acid that allows them to perceive trouble. [...]

Researchers in the US have developed a novel multiplexed diagnostic platform based on CRISPR-based approaches and microfluidics - enabling robust and simultaneous surveillance of multiple viruses and viral variants. Currently, the paper is available on the medRxiv* preprint server pending peer review.